EUVIMEDEUVIMED entdecken
Leitlinie

Diabetes Management in Chronic Kidney Disease: Synopsis of the KDIGO 2022 Clinical Practice Guideline Update

Sankar D Navaneethan, Sophia Zoungas iD, M Luiza Caramori, Juliana C N Chan iD, Hiddo J L Heerspink iD, Clint Hurst, Adrian Liew iD, Erin D Michos iD, Wasiu A Olowu, Tami Sadusky, Nikhil Tandon iD, Katherine R Tuttle iD und 10 weitere

Annals of Internal Medicine · 2023-03 · 176 (3) · 381-387

DOI: 10.7326/m22-2904 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Annals of Internal Medicine, 2023-03. Verfasst von Sankar D Navaneethan und 21 weiteren Autor:innen. Beteiligte Einrichtung: Section of Nephrology, Department of Medicine, Selzman Institute for Kidney Health, Baylor College of Medicine, Institute of Clinical and Translation…. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Sodium-Glucose Transporter 2 Inhibitors, Renal Insufficiency, Chronic. Die Arbeit wurde bisher 227-mal zitiert (Crossref) und nennt 33 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Sodium-Glucose Transporter 2 InhibitorsRenal Insufficiency, ChronicHumansKidneyGlucose

Substanzen

Sodium-Glucose Transporter 2 InhibitorsGlucose

Autor:innen und Institutionen

  • Section of Nephrology, Department of Medicine, Selzman Institute for Kidney Health, Baylor College of Medicine, Institute of Clinical and Translational Research, Baylor College of Medicine, and Section of Nephrology, Mi…
  • School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia (S.Z.).
  • Department of Endocrinology and Metabolism, Cleveland Clinic Foundation, Cleveland, Ohio, and Division of Diabetes, Endocrinology and Metabolism, University of Minnesota, Minneapolis, Minnesota (M.L.C.).
  • Department of Medicine and Therapeutics, Hong Kong Institute of Diabetes and Obesity, and Li Ka Shing Institute of Health Science, The Chinese University of Hong Kong, Hong Kong, China (J.C.N.C.).
  • Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands (H.J.L.H.).
  • Houston, Texas (C.H.).

ORCID-Profile: Sophia Zoungas, Juliana C N Chan, Hiddo J L Heerspink, Adrian Liew, Erin D Michos, Nikhil Tandon, Katherine R Tuttle, Christoph Wanner, Jonathan C Craig, David J Tunnicliffe, Marcello Tonelli, Michael Cheung, Amy Earley, Peter Rossing, Ian H de Boer

Zitieren

APA

Navaneethan, S. D., Zoungas, S., Caramori, M. L., Chan, J. C. N., Heerspink, H. J. L., Hurst, C., Liew, A., Michos, E. D., Olowu, W. A., Sadusky, T., Tandon, N., Tuttle, K. R., Wanner, C., Wilkens, K. G., Craig, J. C., Tunnicliffe, D. J., Tonelli, M., Cheung, M., Earley, A., …, & Khunti, K. (2023). Diabetes Management in Chronic Kidney Disease: Synopsis of the KDIGO 2022 Clinical Practice Guideline Update. Annals of Internal Medicine, 176(3), 381-387. https://doi.org/10.7326/m22-2904

Vancouver

Navaneethan SD, Zoungas S, Caramori ML, Chan JCN, Heerspink HJL, Hurst C, et al. Diabetes Management in Chronic Kidney Disease: Synopsis of the KDIGO 2022 Clinical Practice Guideline Update. Annals of Internal Medicine. 2023;176(3):381-387. doi:10.7326/m22-2904

BibTeX
@article{Navaneethan2023,
  author = {Navaneethan, Sankar D and Zoungas, Sophia and Caramori, M Luiza and Chan, Juliana C N and Heerspink, Hiddo J L and Hurst, Clint and Liew, Adrian and Michos, Erin D and Olowu, Wasiu A and Sadusky, Tami and Tandon, Nikhil and Tuttle, Katherine R and Wanner, Christoph and Wilkens, Katy G and Craig, Jonathan C and Tunnicliffe, David J and Tonelli, Marcello and Cheung, Michael and Earley, Amy and Rossing, Peter and de Boer, Ian H and Khunti, Kamlesh},
  title = {Diabetes Management in Chronic Kidney Disease: Synopsis of the KDIGO 2022 Clinical Practice Guideline Update},
  journal = {Annals of Internal Medicine},
  year = {2023},
  volume = {176},
  number = {3},
  pages = {381--387},
  doi = {10.7326/m22-2904}
}
Kostenlos starten →